Compare $ASMB vs $MPLT | Chartloom

Compare

$ASMB vs $MPLT

Assembly Biosciences Inc · MapLight Therapeutics Inc

ASMB

Assembly Biosciences Inc

MPLT

MapLight Therapeutics Inc

Compare $ASMB vs $MPLT

Comparing Assembly Biosciences Inc and MapLight Therapeutics Inc

ASMBAssembly Biosciences Inc

MPLTMapLight Therapeutics Inc

ASMBAssembly Biosciences Inc

Market cap

$466M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

17.93x

Rev growth (TTM)

125.1%

YTD performance

-30.3%

52W performance

-7.7%

FCF yield

-8.3%

MPLTMapLight Therapeutics Inc

Market cap

$400M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-47.3%

52W performance

-51.9%

FCF yield

-43.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ASMB

MPLT

Detailed metrics comparison

ASMB

Assembly Biosciences Inc

MPLT

MapLight Therapeutics Inc

Market Cap

ASMB$466M

MPLT$400M

Enterprise Value

ASMB$434M

MPLT$329M

Price

ASMB$23.53

MPLT$8.83

P/E Ratio

ASMBN/A

MPLTN/A

P/S Ratio

ASMB6.23x

MPLT0.00x

EV/Sales

ASMB5.80x

MPLT0.00x

EV/EBITDA

ASMB0.00x

MPLT0.00x

P/B Ratio

ASMB1.50x

MPLT1.57x

P/FCF Ratio

ASMBN/A

MPLTN/A

EV/FCF

ASMB-11.26x

MPLT-1.88x

PEG Ratio

ASMBN/A

MPLTN/A

Forward P/E (NTM)

ASMBN/A

MPLTN/A

Forward P/S (NTM)

ASMB17.93x

MPLTN/A

Revenue (TTM)

ASMB$75M

MPLT$0

Revenue Growth (YoY)

ASMB125.1%

MPLTN/A

Forward Rev Growth

ASMB2.1%

MPLT949.5%

Gross Margin (TTM)

ASMB0.0%

MPLT0.0%

Operating Margin (TTM)

ASMB0.0%

MPLT0.0%

EBITDA Margin (TTM)

ASMB-11.6%

MPLT0.0%

Net Margin (TTM)

ASMB-0.1%

MPLT0.0%

FCF Margin (TTM)

ASMB-51.5%

MPLTN/A

Net Income (TTM)

ASMB$-42K

MPLT$-230M

FCF (TTM)

ASMB$-39M

MPLT$-175M

EPS (TTM)

ASMB-$0.00

MPLT-$5.06

ROE (TTM)

ASMB-2.0%

MPLT-6384.0%

ROA (TTM)

ASMB-2.0%

MPLT-6033.0%

ROIC (TTM)

ASMB-2.0%

MPLT-6384.0%

Cash

ASMB$32M

MPLT$72M

Debt

ASMB$0

MPLT$0

Net Cash/Debt

ASMB$32M

MPLT$72M

Current Ratio (TTM)

ASMB13.99x

MPLT16.52x

Quick Ratio (TTM)

ASMB13.70x

MPLT15.79x

Debt/Equity (TTM)

ASMB0.00x

MPLT0.00x

Debt/Assets (TTM)

ASMB0.0%

MPLT0.0%

Interest Coverage (TTM)

ASMBN/A

MPLTN/A

Net Debt/EBITDA (TTM)

ASMB0.00x

MPLT0.00x

Beta

ASMB1.21

MPLT0.85

52W Performance

ASMB-7.7%

MPLT-51.9%

YTD Performance

ASMB-30.3%

MPLT-47.3%

% from 52W High

ASMB-40.7%

MPLT-78.2%

% from 52W Low

ASMB8.0%

MPLT1.5%

Asset Turnover (TTM)

ASMB0.28x

MPLT0.00x

FCF Yield (TTM)

ASMB-8.3%

MPLT-43.7%

Earnings Yield (TTM)

ASMB-0.0%

MPLT-57.4%

Dividend Yield (TTM)

ASMBN/A

MPLTN/A

Rule of 40

ASMB73.6

MPLT0.0

EV/GP/RG

ASMBN/A

MPLTN/A

Ticker research

View ASMB research View MPLT research

Metric	ASMB Assembly Biosciences Inc	MPLT MapLight Therapeutics Inc
Market & Valuation
Market Cap	$466M	$400M
Enterprise Value	$434M	$329M
Price	$23.53	$8.83
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	0.00x
EV/Sales	5.80x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.26x	-1.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	17.93x	N/A
Revenue & Growth
Revenue (TTM)	$75M	$0
Revenue Growth (YoY)	125.1%	N/A
Forward Rev Growth	2.1%	949.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11.6%	0.0%
Net Margin (TTM)	-0.1%	0.0%
FCF Margin (TTM)	-51.5%	N/A
Net Income (TTM)	$-42K	$-230M
FCF (TTM)	$-39M	$-175M
EPS (TTM)	-$0.00	-$5.06
ROE (TTM)	-2.0%	-6384.0%
ROA (TTM)	-2.0%	-6033.0%
ROIC (TTM)	-2.0%	-6384.0%
Financial Health
Cash	$32M	$72M
Debt	$0	$0
Net Cash/Debt	$32M	$72M
Current Ratio (TTM)	13.99x	16.52x
Quick Ratio (TTM)	13.70x	15.79x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.85
52W Performance	-7.7%	-51.9%
YTD Performance	-30.3%	-47.3%
% from 52W High	-40.7%	-78.2%
% from 52W Low	8.0%	1.5%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.00x
FCF Yield (TTM)	-8.3%	-43.7%
Earnings Yield (TTM)	-0.0%	-57.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	73.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ASMB research	View MPLT research

Valuation

P/S Ratio

MPLT

0.00x

ASMB

6.23x

EV/FCF

ASMB

-11.26x

MPLT

-1.88x

Growth & revenue

Revenue Growth TTM

ASMB

125.1%

Forward Revenue Growth

MPLT

949.5%

ASMB

2.1%

Profitability & performance

Gross Margin

ASMB

0.0%

MPLT

0.0%

ROE

ASMB

-2.0%

MPLT

-6384.0%

FCF Yield %

ASMB

-8.3%

MPLT

-43.7%

52-Week Performance

ASMB

-7.7%

MPLT

-51.9%

Detailed metrics comparison

ASMB

Assembly Biosciences Inc

MPLT

MapLight Therapeutics Inc

Market Cap

ASMB$466M

MPLT$400M

Enterprise Value

ASMB$434M

MPLT$329M

Price

ASMB$23.53

MPLT$8.83

P/E Ratio

ASMBN/A

MPLTN/A

P/S Ratio

ASMB6.23x

MPLT0.00x

EV/Sales

ASMB5.80x

MPLT0.00x

EV/EBITDA

ASMB0.00x

MPLT0.00x

P/B Ratio

ASMB1.50x

MPLT1.57x

P/FCF Ratio

ASMBN/A

MPLTN/A

EV/FCF

ASMB-11.26x

MPLT-1.88x

PEG Ratio

ASMBN/A

MPLTN/A

Forward P/E (NTM)

ASMBN/A

MPLTN/A

Forward P/S (NTM)

ASMB17.93x

MPLTN/A

Revenue (TTM)

ASMB$75M

MPLT$0

Revenue Growth (YoY)

ASMB125.1%

MPLTN/A

Forward Rev Growth

ASMB2.1%

MPLT949.5%

Gross Margin (TTM)

ASMB0.0%

MPLT0.0%

Operating Margin (TTM)

ASMB0.0%

MPLT0.0%

EBITDA Margin (TTM)

ASMB-11.6%

MPLT0.0%

Net Margin (TTM)

ASMB-0.1%

MPLT0.0%

FCF Margin (TTM)

ASMB-51.5%

MPLTN/A

Net Income (TTM)

ASMB$-42K

MPLT$-230M

FCF (TTM)

ASMB$-39M

MPLT$-175M

EPS (TTM)

ASMB-$0.00

MPLT-$5.06

ROE (TTM)

ASMB-2.0%

MPLT-6384.0%

ROA (TTM)

ASMB-2.0%

MPLT-6033.0%

ROIC (TTM)

ASMB-2.0%

MPLT-6384.0%

Cash

ASMB$32M

MPLT$72M

Debt

ASMB$0

MPLT$0

Net Cash/Debt

ASMB$32M

MPLT$72M

Current Ratio (TTM)

ASMB13.99x

MPLT16.52x

Quick Ratio (TTM)

ASMB13.70x

MPLT15.79x

Debt/Equity (TTM)

ASMB0.00x

MPLT0.00x

Debt/Assets (TTM)

ASMB0.0%

MPLT0.0%

Interest Coverage (TTM)

ASMBN/A

MPLTN/A

Net Debt/EBITDA (TTM)

ASMB0.00x

MPLT0.00x

Beta

ASMB1.21

MPLT0.85

52W Performance

ASMB-7.7%

MPLT-51.9%

YTD Performance

ASMB-30.3%

MPLT-47.3%

% from 52W High

ASMB-40.7%

MPLT-78.2%

% from 52W Low

ASMB8.0%

MPLT1.5%

Asset Turnover (TTM)

ASMB0.28x

MPLT0.00x

FCF Yield (TTM)

ASMB-8.3%

MPLT-43.7%

Earnings Yield (TTM)

ASMB-0.0%

MPLT-57.4%

Dividend Yield (TTM)

ASMBN/A

MPLTN/A

Rule of 40

ASMB73.6

MPLT0.0

EV/GP/RG

ASMBN/A

MPLTN/A

Ticker research

View ASMB research View MPLT research

Metric	ASMB Assembly Biosciences Inc	MPLT MapLight Therapeutics Inc
Market & Valuation
Market Cap	$466M	$400M
Enterprise Value	$434M	$329M
Price	$23.53	$8.83
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	0.00x
EV/Sales	5.80x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.26x	-1.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	17.93x	N/A
Revenue & Growth
Revenue (TTM)	$75M	$0
Revenue Growth (YoY)	125.1%	N/A
Forward Rev Growth	2.1%	949.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11.6%	0.0%
Net Margin (TTM)	-0.1%	0.0%
FCF Margin (TTM)	-51.5%	N/A
Net Income (TTM)	$-42K	$-230M
FCF (TTM)	$-39M	$-175M
EPS (TTM)	-$0.00	-$5.06
ROE (TTM)	-2.0%	-6384.0%
ROA (TTM)	-2.0%	-6033.0%
ROIC (TTM)	-2.0%	-6384.0%
Financial Health
Cash	$32M	$72M
Debt	$0	$0
Net Cash/Debt	$32M	$72M
Current Ratio (TTM)	13.99x	16.52x
Quick Ratio (TTM)	13.70x	15.79x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.85
52W Performance	-7.7%	-51.9%
YTD Performance	-30.3%	-47.3%
% from 52W High	-40.7%	-78.2%
% from 52W Low	8.0%	1.5%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.00x
FCF Yield (TTM)	-8.3%	-43.7%
Earnings Yield (TTM)	-0.0%	-57.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	73.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ASMB research	View MPLT research